Teething products containing lidocaine to become 'P' medicines

All oral lidocaine-containing preparations indicated...

Update on dermatological signs of child abuse with a free interactive learning module from MIMS Learning

MIMS Learning is offering an interactive module on...

New salmeterol/fluticasone inhaler for adult and childhood asthma

The new pressurised metered-dose inhaler (MDI) Combisal...

Long-acting anticholinergic licensed for childhood asthma

Spiriva Respimat (tiotropium) is now licensed for use...

No need to treat most functional gastric disorders in infants

Most functional gastrointestinal problems in infants...

Emollient bath additives 'no benefit' in childhood eczema

Emollient bath additives provide no clinical benefit...

Increasing inhaled steroid doses may not prevent asthma exacerbations in children

Children with mild to moderate asthma do not benefit...

Don't prescribe antibiotics for most sore throats, says NICE

New guidance from NICE says healthcare professionals...

Cows' milk allergy warning over methylprednisolone use

Lactose-containing methylprednisolone preparations...

Hepatitis B vaccination added to routine schedule

The hexavalent DTaP/IPV/HiB/HBV vaccine Infanrix hexa...

Flu vaccines for 2017/18 season

Vaccines for the 2017/18 flu season are expected to...

New vaccination option for meningitis B

Trumenba is now one of two meningitis B vaccines available...

New aprepitant suspension for use in children

Infographic: Inappropriate prescribing of antidepressants in children and adolescents

Prescribing of antidepressants in children and adolescents...

Infographic: High levels of antibiotic resistance in paediatric urinary infections

Antibiotic resistance in paediatric urinary tract infections...

Guanfacine: new option in ADHD unresponsive to stimulants

Guanfacine (Intuniv) is a once-daily treatment for...

Routine vaccination begins for meningitis B and ACWY

New vaccination programmes for meningitis B and ACWY

Two new vaccination programmes are to be launched in...

Change to Yellow Card reporting in children

The MHRA no longer requires all suspected adverse drug...

Cayston now indicated from six years

Cayston (aztreonam) has been licensed for use in children...